Federal Register / Vol. 70, No. 194 / Friday, October 7, 2005 / Notices 58721 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel 06–19, Review R13. 

Date: October 27, 2005. 

Time: 11 a.m. to 12 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892, (telephone Conference Call). 

Contact Person: Sooyoun (Sonia) Kim, MS, 

Associate SRA, Scientific Review Branch, 

Division of Extramural Research, National 

Inst. of Dental & Craniofacial Research, 

National Institute of Health, Bethesda, MD 

20892; (301) 594–4827. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel 06–21 Review R13. 

Date: November 2, 2005. 

Time: 12:30 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892, (Telephone Conference Call). 

Contact Person: Mary Kelly, Scientific 

Review Specialist, National Institute of 

Dental & Craniofacial Res., 45 Center Drive, 

Natcher Bldg., RM 4AN38J, Bethesda, MD 

20892–6402; (301) 594–4809; 

mary_kelly@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: September 29, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–20248 Filed 10–6–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute of 

Mental Health Special Emphasis Panel, 

October 20, 2005, 8:30 a.m. to October 

21, 2005, 3 p.m., Holiday Inn Select 

Bethesda, 8120 Wisconsin Ave., 

Bethesda, MD, 20814 which was 

published in the Federal Register on 

September 9, 2005, 70 FR 53674–53675. 

The dates and times of the meeting 

are the same but the location has 

changed to the Marriott Bethesda Suites, 

6711 Democracy Boulevard, Bethesda, 

MD. The meeting is closed to the public. 

Dated: September 30, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–20249 Filed 10–6–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (U.S.C. Appendix 2), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; Member 

Conflict 

Date: October 6, 2005 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Mark R. Green, PhD, 

Deputy Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1431, mgren1@nida.nih.gov 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel 

Date: November 8, 2005 

Time: 11:05 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call) 

Contact Person: Mark Swieter, PhD, Chief, 

Training and Special Projects Review Branch, 

Office of Extramural Affairs, National 

Institute on Drug Abuse, NIH, DHHS, 6101 

Executive Boulevard, Suite 220, Bethesda, 

MD 20892–8401, (301) 435–1389, 

ms80x@nih.gov 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse Research 

Programs, National Institutes of Health, HHS) 

Dated: September 30, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–20253 Filed 10–6–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Advisory Committee on Research on 

Women’s Health. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Advisory Committee 

on Research on Women’s Health 

Date: November 9–10, 2005 

Time: November 9, 2005, 9 a.m. to 5 p.m. 

Agenda: Provide advice to the Office of 

Research on Women’s Health (ORWH) on 

appropriate research activities with respect to 

women’s health and related studies to be 

undertaken by the national research 

institutes; to provide recommendations 

regarding ORWH activities; to meet the 

mandates of the office; and for discussion of 

scientific issues. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 6, Bethesda, MD 20892. 

Time: November 10, 2005, 9 a.m. to 12:30 

p.m. 

Agenda: Same as above. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 6, Bethesda, MD 20892. 

Contact Person: Joyce Rudick, Director, 

Programs & Management, Office of Research 

on Women’s Health, Office of the Director, 

National Institutes of Health, Building 1, 

Room 201, Bethesda, MD 20892, (301) 402–

1770. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www4.od.nih.gov/orwh/, where an agenda 

58722 Federal Register / Vol. 70, No. 194 / Friday, October 7, 2005 / Notices 

and any additional information for the 

meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immonodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: September 16, 2005. 

Anthony M. Coelho, Jr. 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–20224 Filed 10–6–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Renal and Urological 

Studies integrated Review Group Cellular 

and Molecular Biology of the Kidney Study 

Section. 

Date: October 17–18, 2005. 

Time: 8 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Shirley Hilden, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National institutes of 

Health, 6701 Rockledge Drive, Room 4218, 

MSC 7814, Bethesda, MD 20892, (301) 435–

1198, hildens@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Bioengineering Fellowships. 

Date: October 19, 2005. 

Time: 11 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Khalid Masood, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5095H, 

MSC 7854, Bethesda, MD 20892, 301–402–

3962, masoodk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Development of Methods for In Vivo Imaging 

and Bioengineering Research. 

Date: October 24–25, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select Bethesda, 8120 

Wisconsin Ave, Bethesda, MD 20814. 

Contact Person: Behrouz Shabestari, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5106, 

MSC 7854, Bethesda, MD 20892, (301) 435–

2409, shabestb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Molecular 

Oncogenesis. 

Date: October 24–25, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Joanna M. Watson, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6046–G, 

MSC 7804, Bethesda, MD 20892, (301) 435–

1048, watsonjo@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group, 

Host Interactions with Bacterial Pathogens 

Study Section. 

Date: October 24–25, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia 

Avenue, NW., Washington, DC 20037. 

Contact Person: Timothy J. Henry, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3212, 

MSC 7808, Bethesda, MD 20892, (301) 435–

1147, henryt@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group, 

Virology—B Study Section. 

Date: October 24–25, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia 

Avenue, NW., Washington, DC 20037. 

Contact Person: Robert Freund, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3200, 

MSC 7848, Bethesda, MD 20892, (301) 435–

1050, freundr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Special Emphasis Panel, Small Business 

Medical Imaging: Ultrasound. 

Date: October 24, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select Bethesda, 8120 

Wisconsin Ave., Bethesda, MD 20814. 

Contact Person: Hector Lopez, DSC, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5120, 

MSC 7854, Bethesda, MD 20892, (301) 435–

2392, lopezh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Clinical 

Neurophysiology, Devices and 

Neuroprosthetics/Brain Disorders and 

Clinical Neuroscience/SBIR. 

Date: October 24–25, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select Bethesda, 8120 

Wisconsin Ave., Bethesda, MD 20814. 

Contact Person: Vinod Charles, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5196, 

MSC 7846, Bethesda, MD 20892, (301) 435–

0902, charlesvi@csr.nih.gov. 

Name of Committee: Oncological Sciences 

Integrated Review Group, Cancer Genetics 

Study Section. 

Date: October 24–25, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Zhiqiang Zou, PhD, MD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6190, 

MSC 7804, Bethesda, MD 20892, (301) 451–

0132, zouzhiq@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business Cardiovascular Devices. 

Date: October 24–25, 2005. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select, 8120 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Roberto J. Matus, MD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7854, Bethesda, MD 20892, (301) 435–

2204, matusr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Neurodegeneration, Neuroinflammation, 

Oxidate Stress and Mitochondria. 

Date: October 24–25, 2005. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Omni Shoreham, 2500 Calvert Street 

NW., Washington, DC 20037. 

Contact Person: Carole L. Jelsema, PhD, 

Chief and Scientific Review Administrator,